Tongjitang Chinese Medicines Company, which makes and markets traditional Chinese medicines, announced a plan to buy back up to $20 million of its shares. The move could have a significant effect on Tongjitang, because the company has a market capitalization of only $128 million at its current price of $3.80. The buyback does not require management to purchase the full $20 million, and it remains subject to shareholder approval. More details...

Stock Symbols: (NYSE: TCM)